Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 31.68% ano a ano.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 2.25B.
Sobreavaliada
O PE mais recente da empresa é -1.01, em uma faixa percentil alta de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 68.97M ações, uma redução de 8.93% em relação ao trimestre anterior.
Mantido por Mason Hawkins
O Super Investidor Mason Hawkins possui 43.70K ações desta empresa.